Di Giorgio A - Search Results

1

Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.

Tran TPA, Poulet S, Pernak M, Rayar A, Azoulay S, Di Giorgio A, Duca M. Tran TPA, et al. Among authors: di giorgio a. RSC Med Chem. 2021 Dec 16;13(3):311-319. doi: 10.1039/d1md00345c. eCollection 2022 Mar 23. RSC Med Chem. 2021. PMID: 35434630 Free PMC article.

2

Polyamide amino acids: a new class of RNA ligands.

Bonnard V, Azoulay S, Di Giorgio A, Patino N. Bonnard V, et al. Among authors: di giorgio a. Chem Commun (Camb). 2009 May 7;(17):2302-4. doi: 10.1039/b815324h. Epub 2009 Mar 6. Chem Commun (Camb). 2009. PMID: 19377666

3

Fluorescent labeling of human mesenchymal stem cells by thiophene fluorophores conjugated to a lipophilic carrier.

Duca M, Dozza B, Lucarelli E, Santi S, Di Giorgio A, Barbarella G. Duca M, et al. Among authors: di giorgio a. Chem Commun (Camb). 2010 Nov 14;46(42):7948-50. doi: 10.1039/c0cc01918f. Epub 2010 Sep 22. Chem Commun (Camb). 2010. PMID: 20862424

4

Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.

Bonnard V, Pascale L, Azoulay S, Di Giorgio A, Rogez-Kreuz C, Storck K, Clayette P, Patino N. Bonnard V, et al. Among authors: di giorgio a. Bioorg Med Chem. 2010 Nov 1;18(21):7432-8. doi: 10.1016/j.bmc.2010.09.002. Epub 2010 Sep 7. Bioorg Med Chem. 2010. PMID: 20889349 Free article.

5

Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.

Pascale L, Azoulay S, Di Giorgio A, Zenacker L, Gaysinski M, Clayette P, Patino N. Pascale L, et al. Among authors: di giorgio a. Nucleic Acids Res. 2013 Jun;41(11):5851-63. doi: 10.1093/nar/gkt237. Epub 2013 Apr 19. Nucleic Acids Res. 2013. PMID: 23605042 Free PMC article.

6

Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.

Tran TP, Vo DD, Di Giorgio A, Duca M. Tran TP, et al. Among authors: di giorgio a. Bioorg Med Chem. 2015 Sep 1;23(17):5334-44. doi: 10.1016/j.bmc.2015.07.062. Epub 2015 Jul 30. Bioorg Med Chem. 2015. PMID: 26264847

7

Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.

Pascale L, González AL, Di Giorgio A, Gaysinski M, Teixido Closa J, Tejedor RE, Azoulay S, Patino N. Pascale L, et al. Among authors: di giorgio a. J Biomol Struct Dyn. 2016 Nov;34(11):2327-38. doi: 10.1080/07391102.2015.1114971. Epub 2016 Jan 6. J Biomol Struct Dyn. 2016. PMID: 26524629

8

Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.

Vo DD, Tran TP, Staedel C, Benhida R, Darfeuille F, Di Giorgio A, Duca M. Vo DD, et al. Among authors: di giorgio a. Chemistry. 2016 Apr 4;22(15):5350-62. doi: 10.1002/chem.201505094. Epub 2016 Mar 1. Chemistry. 2016. PMID: 26928593

9

Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.

Di Giorgio A, Tran TP, Duca M. Di Giorgio A, et al. Future Med Chem. 2016 May;8(7):803-16. doi: 10.4155/fmc-2016-0018. Epub 2016 May 5. Future Med Chem. 2016. PMID: 27149207 Review.

10

Exploring the impact of the side-chain length on peptide/RNA binding events.

Sbicca L, González AL, Gresika A, Di Giorgio A, Closa JT, Tejedor RE, Andréola ML, Azoulay S, Patino N. Sbicca L, et al. Among authors: di giorgio a. Phys Chem Chem Phys. 2017 Jul 19;19(28):18452-18460. doi: 10.1039/c7cp03726k. Phys Chem Chem Phys. 2017. PMID: 28681892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters